APA (7th ed.) Citation

C, B., L, A., E, O., M, C., E, C., K, N., . . . L, O. (2016). OTX015 (MK-8628), a novel BET inhibitor, displays in vitro and in vivo antitumor effects alone and in combination with conventional therapies in glioblastoma models. International journal of cancer, 139(9), 2047. https://doi.org/10.1002/ijc.30256

Chicago Style (17th ed.) Citation

C, Berenguer-Daizé, et al. "OTX015 (MK-8628), a Novel BET Inhibitor, Displays in Vitro and in Vivo Antitumor Effects Alone and in Combination with Conventional Therapies in Glioblastoma Models." International Journal of Cancer 139, no. 9 (2016): 2047. https://doi.org/10.1002/ijc.30256.

MLA (9th ed.) Citation

C, Berenguer-Daizé, et al. "OTX015 (MK-8628), a Novel BET Inhibitor, Displays in Vitro and in Vivo Antitumor Effects Alone and in Combination with Conventional Therapies in Glioblastoma Models." International Journal of Cancer, vol. 139, no. 9, 2016, p. 2047, https://doi.org/10.1002/ijc.30256.